 CAMBRIDGE, Mass. SALISBURY, England--BUSINESS WIRE--KalVista Pharmaceuticals, Inc. NASDAQ: KALV, a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced it will participate in a fireside chat at the following investor conferences: Stifel 2021 Virtual Healthcare Conference on Monday, November 15, 2021 at 9:20 a.m. EST Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at 5: 